{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:56Z","timestamp":1787020976757,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Peking union medical foundation-Ruiyi Emergency Medical Research Fund","award":["PUMF01010010-2025-21"],"award-info":[{"award-number":["PUMF01010010-2025-21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Sepsis-induced liver injury (SILI) indicates liver functional or structural impairment occurring during sepsis and is one of the common complications of sepsis. N6-methyladenosine (m6A) modification plays a significant role in the pathological processes of SILI, but its specific mechanisms remain unclear and require further elucidation. In this study, an experimental sepsis model exhibiting characteristic symptoms and hepatic damage was established through cecal ligation and puncture (CLP) surgery. Comprehensive analyses of hepatic tissues from CLP-treated and Sham operation mice through RNA Sequencing (RNA-Seq) and Methylated RNA Immunoprecipitation Sequencing (MeRIP-Seq) methodologies revealed distinct m6A peaks and differentially expressed genes (DEGs). A total of 2002 m6A peaks were detected (|log2FC|\u2265\u20091,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Our analyses demonstrated that 71% of m6A peaks clustered within the coding sequences (CDS) and 3' untranslated region starts (3' UTR) of transcripts. When compared with the Sham group, the CLP group showed an increase of 1741 DEGs and a decrease of 1815 DEGs. And 458 genes exhibited both m6A modifications and changes in mRNA levels. Functional enrichment assessments through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed that m6A-modified hepatic genes in septic mice were significantly enriched in the cytoplasm, nucleus and protein binding, which mainly involved in regulating cell survival, immune responses, inflammatory responses and other related pathways. The results of Cell Counting Kit-8 (CCK8) assay and 5-ethynyl-2'-deoxyuridine (EdU) assay showed that the proliferation ability of liver cell lines was enhanced after knocking down m6A regulatory factor METTL3, which indicates the m6A modifications play an important role in the proliferation ability of normal liver cells. This study validated the presence of m6A-epitranscriptomic modifications and their regulatory roles in sepsis-affected hepatic systems, establishing comprehensive m6A landscapes in septic liver tissues.\n                  <\/jats:p>","DOI":"10.1186\/s40001-025-02985-7","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T02:14:34Z","timestamp":1754619274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Construction of RNA m6A profiles in liver tissue of mice in sepsis-induced liver injury based on m6A MeRIP-seq and RNA-seq"],"prefix":"10.1186","volume":"30","author":[{"given":"Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2985_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/1874467211666180619124531","volume":"11","author":"ACA Naime","year":"2018","unstructured":"Naime ACA, Ganaes JOF, Lopes-Pires ME. Sepsis: the involvement of platelets and the current treatments. Curr Mol Pharmacol. 2018;11:261\u20139.","journal-title":"Curr Mol Pharmacol"},{"key":"2985_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","volume":"392","author":"M Cecconi","year":"2018","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75\u201387.","journal-title":"Lancet"},{"key":"2985_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMra2403213","volume":"391","author":"NJ Meyer","year":"2024","unstructured":"Meyer NJ, Prescott HC. Sepsis and septic shock. N Engl J Med. 2024;391:2133\u201346.","journal-title":"N Engl J Med"},{"key":"2985_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jgar.2017.06.013","volume":"10","author":"S Esposito","year":"2017","unstructured":"Esposito S, De Simone G, Boccia G, De Caro F, Pagliano P. Sepsis and septic shock: new definitions, new diagnostic and therapeutic approaches. J Global Antimicrob Resist. 2017;10:204\u201312.","journal-title":"J Global Antimicrob Resist"},{"key":"2985_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2174\/138920212803759712","volume":"13","author":"Y-T Lin","year":"2012","unstructured":"Lin Y-T, Verma A, Hodgkinson CP. Toll-like receptors and human disease: lessons from single nucleotide polymorphisms. Curr Genomics. 2012;13:633\u201345.","journal-title":"Curr Genomics"},{"key":"2985_CR6","first-page":"412","volume":"23","author":"Y-C Han","year":"2023","unstructured":"Han Y-C, Shen Z-J, Xiang R-L, Lu B, Qian H, Li J-Y, et al. Long noncoding RNA and mRNA expression profiles in rats with LPS-induced myocardial dysfunction. Curr Genomics. 2023;23:412\u201323.","journal-title":"Curr Genomics"},{"key":"2985_CR7","doi-asserted-by":"publisher","first-page":"G968","DOI":"10.1152\/ajpgi.2001.280.5.G968","volume":"280","author":"YG Weiss","year":"2001","unstructured":"Weiss YG, Bellin L, Kim PK, Andrejko KM, Haaxma CA, Raj N, et al. Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats. Am J Physiol Gastrointest Liver Physiol. 2001;280:G968-973.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2985_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14:55\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2985_CR9","first-page":"123","volume":"19","author":"M Bauer","year":"2013","unstructured":"Bauer M, Press AT, Trauner M. The liver in sepsis: patterns of response and injury. Curr Opin Crit Care. 2013;19:123\u20137.","journal-title":"Curr Opin Crit Care"},{"key":"2985_CR10","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1097\/00003246-200212000-00016","volume":"30","author":"JP Cobb","year":"2002","unstructured":"Cobb JP, Laramie JM, Stormo GD, Morrissey JJ, Shannon WD, Qiu Y, et al. Sepsis gene expression profiling: murine splenic compared with hepatic responses determined by using complementary DNA microarrays. Crit Care Med. 2002;30:2711\u201321.","journal-title":"Crit Care Med"},{"key":"2985_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jss.2011.11.1031","volume":"176","author":"Q Yang","year":"2012","unstructured":"Yang Q, Mattick JSA, Orman MA, Nguyen TT, Ierapetritou MG, Berthiaume F, et al. Dynamics of hepatic gene expression profile in a rat cecal ligation and puncture model. J Surg Res. 2012;176:583\u2013600.","journal-title":"J Surg Res"},{"key":"2985_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1164\/rccm.201404-0624OC","volume":"190","author":"RJ Langley","year":"2014","unstructured":"Langley RJ, Tipper JL, Bruse S, Baron RM, Tsalik EL, Huntley J, et al. Integrative \u201comic\u201d analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med. 2014;190:445\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"2985_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181\u2013247.","journal-title":"Intensive Care Med"},{"key":"2985_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19:88.","journal-title":"Mol Cancer"},{"key":"2985_CR15","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/cvr\/cvab160","volume":"118","author":"R Kumari","year":"2022","unstructured":"Kumari R, Ranjan P, Suleiman ZG, Goswami SK, Li J, Prasad R, et al. mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification. Cardiovasc Res. 2022;118:1680\u201392.","journal-title":"Cardiovasc Res"},{"key":"2985_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"X-Y Chen","year":"2019","unstructured":"Chen X-Y, Zhang J, Zhu J-S. The role of m6A RNA methylation in human cancer. Mol Cancer. 2019;18:103.","journal-title":"Mol Cancer"},{"key":"2985_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.21037\/atm.2020.03.07","volume":"8","author":"S Zhang","year":"2020","unstructured":"Zhang S, Liu F, Wu Z, Xie J, Yang Y, Qiu H. Contribution of m6A subtype classification on heterogeneity of sepsis. Ann Transl Med. 2020;8:306.","journal-title":"Ann Transl Med"},{"key":"2985_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12943-019-1106-z","volume":"18","author":"T Lan","year":"2019","unstructured":"Lan T, Li H, Zhang D, Xu L, Liu H, Hao X, et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer. 2019;18:186.","journal-title":"Mol Cancer"},{"key":"2985_CR19","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1038\/s41401-023-01065-y","volume":"44","author":"X-L He","year":"2023","unstructured":"He X-L, Chen J-Y, Feng Y-L, Song P, Wong YK, Xie L-L, et al. Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate. Acta Pharmacol Sin. 2023;44:1801\u201314.","journal-title":"Acta Pharmacol Sin"},{"key":"2985_CR20","first-page":"1233","volume":"3","author":"JA Bokar","year":"1997","unstructured":"Bokar JA, Shambaugh ME, Polayes D, Matera AG, Rottman FM. Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA. 1997;3:1233\u201347.","journal-title":"RNA"},{"key":"2985_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/17501911.2025.2494983","volume":"17","author":"Z Wu","year":"2025","unstructured":"Wu Z, Miao C, Zhang H. METTL3-mediated m6A modification in sepsis: current evidence and future perspectives. Epigenomics. 2025;17:611\u201323.","journal-title":"Epigenomics"},{"key":"2985_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nprot.2008.214","volume":"4","author":"D Rittirsch","year":"2009","unstructured":"Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 2009;4:31\u20136.","journal-title":"Nat Protoc"},{"key":"2985_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1186\/s13054-020-03327-1","volume":"24","author":"J Sun","year":"2020","unstructured":"Sun J, Zhang J, Wang X, Ji F, Ronco C, Tian J, et al. Gut-liver crosstalk in sepsis-induced liver injury. Crit Care. 2020;24:614.","journal-title":"Crit Care"},{"key":"2985_CR24","unstructured":"Chen M, Zhang Y, Wang Y, Gulifeire T, Yu X. Role and mechanism of SIRT1 in regulating Nrf2\/HO-1 signaling pathway in septic liver injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023;35:598\u2013603."},{"key":"2985_CR25","doi-asserted-by":"crossref","unstructured":"Shen R, Jiang Z, Wang H, Zheng Z, Jiang X. Molecular mechanisms of m6A modifications regulating tumor radioresistance. Mol Med. 2025;31:64.","DOI":"10.1186\/s10020-025-01121-9"},{"key":"2985_CR26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/cac2.12161","volume":"41","author":"S Dong","year":"2021","unstructured":"Dong S, Wu Y, Liu Y, Weng H, Huang H. N6 -methyladenosine steers RNA metabolism and regulation in cancer. Cancer Commun. 2021;41:538\u201359.","journal-title":"Cancer Commun"},{"key":"2985_CR27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00109-024-02417-9","volume":"102","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Huang J, Zhao K, Li M, Wang S. Ubiquitination and deubiquitination in the regulation of N6-methyladenosine functional molecules. J Mol Med. 2024;102:337\u201351.","journal-title":"J Mol Med"},{"key":"2985_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.818357","volume":"13","author":"F Guo","year":"2022","unstructured":"Guo F, Zhang Y, Ma J, Yu Y, Wang Q, Gao P, et al. M6a mrna methylation was associated with gene expression and lipid metabolism in liver of broilers under lipopolysaccharide stimulation. Front Genet. 2022;13: 818357.","journal-title":"Front Genet"},{"key":"2985_CR29","first-page":"628","volume":"57","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Guo F, Zhao R. Hepatic expression of FTO and fatty acid metabolic genes changes in response to lipopolysaccharide with alterations in m6A modification of relevant mRNAs in the chicken. Br Poult Sci. 2016;57:628\u201335.","journal-title":"Br Poult Sci"},{"key":"2985_CR30","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1016\/j.ymthe.2024.10.025","volume":"32","author":"F-F Chan","year":"2024","unstructured":"Chan F-F, Kwan KK-L, Seoung D-H, Chin DW-C, Ng IO-L, Wong CC-L, et al. N-methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer. Mol Ther. 2024;32:4435\u201347.","journal-title":"Mol Ther"},{"key":"2985_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174749","volume":"917","author":"Y Huang","year":"2022","unstructured":"Huang Y, Chen S, Pang L, Feng Z, Su H, Zhu W, et al. Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A. Eur J Pharmacol. 2022;917: 174749.","journal-title":"Eur J Pharmacol"},{"key":"2985_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149125","volume":"936","author":"Z Li","year":"2025","unstructured":"Li Z, Lao Y, Yan R, Li F, Guan X, Dong Z. N6-methyladenosine in inflammatory diseases: important actors and regulatory targets. Gene. 2025;936: 149125.","journal-title":"Gene"},{"key":"2985_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111302","volume":"122","author":"Q-Q Dong","year":"2024","unstructured":"Dong Q-Q, Yang Y, Tao H, Lu C, Yang J-J. m6A epitranscriptomic and epigenetic crosstalk in liver fibrosis: special emphasis on DNA methylation and non-coding RNAs. Cell Signal. 2024;122: 111302.","journal-title":"Cell Signal"},{"key":"2985_CR34","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1080\/15548627.2023.2196876","volume":"19","author":"Y Li","year":"2023","unstructured":"Li Y, Xu J, Chen W, Wang X, Zhao Z, Li Y, et al. Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins contributing to septic liver injury. Autophagy. 2023;19:2504\u201319.","journal-title":"Autophagy"},{"key":"2985_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104468","volume":"148","author":"F Wang","year":"2020","unstructured":"Wang F, Wang M, Wang J, Chen M, Sun S, Yao S, et al. Maresin1 ameliorates sepsis-associated lung injury by inhibiting the activation of the JAK2\/STAT3 and MAPK\/ NF-\u03baB signaling pathways. Microb Pathogen. 2020;148: 104468.","journal-title":"Microb Pathogen"},{"key":"2985_CR36","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3389\/fphar.2019.01323","volume":"10","author":"S Sun","year":"2019","unstructured":"Sun S, Wang J, Wang J, Wang F, Yao S, Xia H. Maresin 1 mitigates sepsis-associated acute kidney injury in mice via inhibition of the NF-\u03baB\/STAT3\/MAPK pathways. Front Pharmacol. 2019;10:1323.","journal-title":"Front Pharmacol"},{"key":"2985_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113492","volume":"143","author":"W Xu","year":"2024","unstructured":"Xu W, Hou H, Yang W, Tang W, Sun L. Immunologic role of macrophages in sepsis-induced acute liver injury. Int Immunopharmacol. 2024;143: 113492.","journal-title":"Int Immunopharmacol"},{"key":"2985_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113178","volume":"142","author":"K Xie","year":"2024","unstructured":"Xie K, Wang F, Yang Y, Pan S, Wang J, Xiao N, et al. Monotropein alleviates septic acute liver injury by restricting oxidative stress, inflammation, and apoptosis via the AKT (Ser473)\/GSK3\u03b2 (Ser9)\/fyn\/NRF2 pathway. Int Immunopharmacol. 2024;142: 113178.","journal-title":"Int Immunopharmacol"},{"key":"2985_CR39","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13046-022-02528-6","volume":"41","author":"L Zhao","year":"2022","unstructured":"Zhao L, Kang M, Liu X, Wang Z, Wang Y, Chen H, et al. UBR7 inhibits HCC tumorigenesis by targeting Keap1\/Nrf2\/Bach1\/HK2 and glycolysis. J Exp Clin Cancer Res. 2022;41:330.","journal-title":"J Exp Clin Cancer Res"},{"key":"2985_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140523","volume":"302","author":"L Wang","year":"2025","unstructured":"Wang L, ChenLiu Z, Wang D, Tang D. Cross-talks of GSH, mitochondria, RNA m6A modification, NRF2, and p53 between ferroptosis and cuproptosis in HCC: a review. Int J Biol Macromol. 2025;302: 140523.","journal-title":"Int J Biol Macromol"},{"key":"2985_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1874467210801010068","volume":"1","author":"SC Tauber","year":"2008","unstructured":"Tauber SC, Nau R. Immunomodulatory properties of antibiotics. Curr Mol Pharmacol. 2008;1:68\u201379.","journal-title":"Curr Mol Pharmacol"},{"key":"2985_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-023-02638-9","volume":"42","author":"Y Sun","year":"2023","unstructured":"Sun Y, Shen W, Hu S, Lyu Q, Wang Q, Wei T, et al. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Exp Clin Cancer Res. 2023;42:65.","journal-title":"J Exp Clin Cancer Res"},{"key":"2985_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cpan.2024.12.002","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang S, Liu K, Hu X, Gu X. Advances in drug discovery based on network pharmacology and omics technology. Curr Pharm Anal. 2024;21:33\u201343.","journal-title":"Curr Pharm Anal"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02985-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:29:40Z","timestamp":1757356180000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02985-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2985"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02985-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments in this study were approved by the Ethics Committees of the First Affiliated Hospital of Zhengzhou University (Approval No. 2025-KY-0544\u2013001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"723"}}